Our products and services
Medicines Assessment provides expertise in pharmacology, clinical pharmacology and medicines regulation. Our aim is to increase efficiency when bringing medicines to market.
We advise on:
• clinical trial design
• new drug applications
• generics and variations
• scientific advice
• European applications
• investment decisions
• due diligence
From candidate molecules to approved medicines, our business supports knowledge based decision making of pharmaceutical risk benefit analysis.
Drug Discovery: Lessons from Evolution, see:
British Pharmacology Society Visitor/Lecturer to Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists, 2013.
" ..your talk was one of the most impressive and entertaining presentations that I have ever seen .." - Professor David Le Couteur, President.